Robinson, Stacey L.
Bendrath, Sophie C.
Yates, Elizabeth M.
Thiele, Todd E. http://orcid.org/0000-0001-8908-9256
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA025811, AA028268, AA029935, AA013573, AA022048, AA025809)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
Article History
Received: 10 February 2023
Revised: 22 August 2023
Accepted: 12 September 2023
First Online: 27 September 2023
Competing interests
: The authors declare no competing financial interests. Dr. Thiele owns shares of Glauser Life Sciences, a company focusing on the development of therapeutics for mental health disorders. The work that is presented in this paper is not directly related to the scientific aims of Glauser Life Sciences.